Clinical Trials Directory

Trials / Unknown

UnknownNCT05477030

Effect of Automated Insulin Delivery on Early-stage Diabetic Complications

Effect of Automated Insulin Delivery With Advanced Closed-loop on Glucose Outcomes and Early-stage Diabetic Complications

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
52 (estimated)
Sponsor
University of Milan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Aim of this study is to verify the effects of an advanced HCL (Medtronic Minimed™ 780G) compared to SAP with PLGS on metabolic outcomes and markers of early microvascular damage in a population of adults with T1D previously treated with CSII. Evaluation of endothelial disfunction and autonomic neuropathy will also be performed.

Detailed description

New algorithms for the automation of insulin delivery (AID) are showing great benefit on glucose control in people with type 1 diabetes. Indeed, Hybrid closed loop (HCL) systems can improve HbA1c levels, percentage of time in defined glucose range, time below range and time over range, according to RCT and observational studies results. However, scientific evidences demonstrating potential benefits on the reduction of diabetes complications are limited regarding CSII or SAP with demonstrated reduction of cardiovascular mortality, improvement of albuminuria and peripheral nerve damage. Data on AID effects on complications of diabetes are missing. In this study intermediate damage markers will be measured to assess potential effects of AID in comparison to sensor augmented pumps.

Conditions

Interventions

TypeNameDescription
DEVICEMedtronic MiniMed 780G with SmartGuard activationInsulin pump implemented with alghoritm for automatic modulation of insulin delivery (to increase time in glucose range 70-180 mg/dl)
DEVICEMedtronic MiniMed 780G without SmartGuard activationInsulin pump implemented with alghoritm for low glucose insulin suspension (to reduce hypoglycemia rate)

Timeline

Start date
2022-02-23
Primary completion
2023-01-31
Completion
2024-02-23
First posted
2022-07-28
Last updated
2022-07-28

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05477030. Inclusion in this directory is not an endorsement.